Quest Diagnostics completed the acquisition of LifeLabs from OMERS for $985m.

Quest Diagnostics, a diagnostic information services provider, completed the acquisition of LifeLabs, a community laboratory tests provider, from OMERS, an investment company, for $985m. "This acquisition brings together two industry leaders committed to enhancing access to diagnostic innovation for patients in North America. The combination of LifeLabs' strong business and deep community presence with Quest's specialized lab services and expertise creates a powerful opportunity to generate growth while improving care and outcomes for Canada's expanding and aging population," Jim Davis, Quest Diagnostics Chairman, CEO and President.